Skip to content
Toggle main navigation
EndoForum logo
EndoForum logo
  • Join Today
    Log in
    Select an available language
    EN

    Endocrine News

    Endocrine News provides an in-depth look at trends in the field of endocrinology as well as a closer look at recently published research.

    Filter by category
    All
    Adrenal
    Advocacy
    Bone and Mineral
    Cardiometabolic
    Clinical
    COVID-19
    Diabetes
    Diabetes News and Research
    Diabetes Research Articles
    Early Career Corner
    See all

    Results (10)

    Pharma Friday – November 21, 2026

    Pharma Friday – November 21, 2026

    An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Amylyx Pharmaceuticals Presents Results from Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia On November 14, Amylyx Pharmaceuticals, Inc. presented the results from the 16-week double-blind treatment period of the Phase 3 LUCIDITY clinical trial of avexitide, an invest
    November 20, 2026
    Anders Juul Wins 2027 Transatlantic Alliance Award in Endocrinology

    Anders Juul Wins 2027 Transatlantic Alliance Award in Endocrinology

    The Endocrine Society and the European Society of Endocrinology (ESE) are delighted to announce Professor Anders Juul, MD, PhD, DMSc, as the winner of the 2027 Transatlantic Alliance Award. Juul is professor of pediatric endocrinology at the University of Copenhagen and head of the Department of Growth and Reproduction at Rigshospitalet (Copenhagen University Hospital) in […]The post Anders Juul W
    November 17, 2026
    Four Members Authored Sections of the UN Environment Programme/World Health Organization Report

    Four Members Authored Sections of the UN Environment Programme/World Health Organization Report

    Four Endocrine Society experts served as lead section authors of a major new global assessment on endocrine-disrupting chemicals (EDCs) from the United Nations Environment Programme and the World Health Organization. “The State of the Science of Endocrine-disrupting Chemicals 2026 Report” finds strong evidence that exposure to EDCs can cause serious adverse effects in humans and […]The post Four M
    November 17, 2026
    Diabetes Month: The Top Five Endocrine Society Journal Articles on Diabetes of 2026

    Diabetes Month: The Top Five Endocrine Society Journal Articles on Diabetes of 2026

    November is of course National Diabetes Month, and there have been some very interesting developments in the field since last November. We found the top five Endocrine Society journal articles on diabetes from the past year, and we’re proud to show them to you here. Michal Kasher Meron, MD, of Meir Medical Center in Kfar […]The post Diabetes Month: The Top Five Endocrine Society Journal Articles o
    November 10, 2026
    Pharma Friday – October 23, 2026

    Pharma Friday – October 23, 2026

    An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Neurocrine Biosciences Announces Publication in Orphanet Journal of Rare Diseases Advancing Understanding of Hyperphagia in Prader-Willi Syndrome Neurocrine Biosciences, Inc. announced on Oct. 22 a publication of expert perspectives highlighting hyperphagia in Prader-Willi syndrome (PWS) as a com
    October 23, 2026
    Longer Sleep May Be Linked to a Higher Risk of Kidney Disease in People with Type 2 Diabetes

    Longer Sleep May Be Linked to a Higher Risk of Kidney Disease in People with Type 2 Diabetes

    People with type 2 diabetes who sleep longer may have an increased risk of developing or worsening existing diabetic kidney disease, according to a study published in the Journal of the Endocrine Society. Diabetic nephropathy, also known as diabetic kidney disease, is a serious kidney condition caused by long-term damage from type 1 or type […]The post Longer Sleep May Be Linked to a Higher Risk o
    October 8, 2026
    Pharma Friday – Oct. 2, 2026

    Pharma Friday – Oct. 2, 2026

    An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * FDA Approves First Treatment for MCT8 Deficiency On Sept. 28, the U.S. Food and Drug Administration (FDA) approved Emcitate (tiratricol) tablets for oral suspension to treat peripheral thyrotoxicosis (excess thyroid hormone levels in the blood that causes symptoms, such as rapid […]The post Pharm
    October 2, 2026
    Men With Low or High Testosterone May Have Higher Risk of Irregular Heartbeat

    Men With Low or High Testosterone May Have Higher Risk of Irregular Heartbeat

    Men with either low or high testosterone levels may face a higher risk of atrial fibrillation, highlighting the need for personalized testosterone treatment, according to a review of existing evidence on testosterone and heart health published today in the Journal of the Endocrine Society. Co-author Rajat S. Barua, MD, PhD, of Kansas City Veterans Affairs Medical […]The post Men With Low or High T
    September 2, 2026
    ENDO 2026: Progress and Resilience

    ENDO 2026: Progress and Resilience

    ENDO 2026 was another for the record books, which was impressive for a time when healthcare – and the research that informs it – can seem uncertain. But endocrinologists are unflappable, and it was evident this past June. Miles Davis once famously said of jazz that it’s not the notes you play; it’s the notes […]The post ENDO 2026: Progress and Resilience appeared first on Endocrine News.
    August 28, 2026
    Pharma Friday – August 21, 2026

    Pharma Friday – August 21, 2026

    An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Amylyx Pharmaceuticals Announces Positive Topline Results from Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia On August 18, Amylyx Pharmaceuticals, Inc., announced positive topline results from LUCIDITY, a 78-participant, multicenter, randomized, double-blind, placebo
    August 21, 2026
    Contact
    1 (888) 363-6762
    Cookies
    Reselect cookie settings
    Community engagement platform by Hivebrite.